Genmab A (GMAB) Other Operating Expenses (2024 - 2026)

Genmab A's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$65.0 million for Q1 2026.

• Quarterly Other Operating Expenses fell 54.76% year-over-year to -$65.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$321.0 million (down 67.19% YoY) and the FY2025 annual result came in at $423.0 million, up 84.72% from the prior year.
• Other Operating Expenses was -$65.0 million for Q1 2026 at Genmab A, up from -$157.0 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at -$27.0 million in Q1 2024 and bottomed at -$157.0 million in Q3 2025.
• A 3-year average of -$77.1 million and a median of -$65.0 million in 2026 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2025 — Other Operating Expenses sank 80.0% — and 2026, when it tumbled 54.76%.
• Genmab A's Other Operating Expenses stood at -$95.0 million in 2024, then plunged by 65.26% to -$157.0 million in 2025, then jumped by 58.6% to -$65.0 million in 2026.
• Business Quant data shows GMAB's Other Operating Expenses at -$65.0 million in Q1 2026, -$157.0 million in Q3 2025, and -$99.0 million in Q2 2025.